CompoAtlas

CanaMed Maca Energy Plus Capsules

Natural health product licensed in Canada

Other names
Egniol Maca Energy Plus Capsules, Forseti Maca Energy Plus Capsules, Genesis Maca Energy Plus Capsules, Maca Energy Plus Capsules, Quadrant Maca Energy Plus Capsules
Licence holder
CanaMed Life Sciences Inc.
NPN or DIN-HM
80055069
Status
Active licence
Licence date
22 October 2014
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Cucurbita pepo

Source : Plante entière

25 mgNot calculated
Turnera diffusa

Source : Feuille

40 mgNot calculated
Lepidium meyenii

Source : Racine

150 mgNot calculated
Lepidium meyenii

Source : Hypocotyle

150 mgNot calculated

Non-medicinal ingredients

Dioxyde de silicium colloïdal, Stéarate de magnésium, Gélatine, Maltodextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 yearsminimum: 2 Capsule ; maximum: 3 Capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to support emotional aspects of sexual health. Helps to support healthy mood balance during menopause. Provides antioxidants.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80055069

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line